Biochemical Engineering Special Interest Group
biological engineering professionals
19 June 2017

FDA approves Reneuron's retinal stem cell therapy candidate

The FDA has approved the cryopreserved formulation of Reneuron's human retinal progenitor cell (hRPC) therapeutic candidate and they have now started treating patients with this formulation in their ongoing US Phase I/II study clinical trial in retinitis pigmentosa (RP) patients. Source: Reneuron press release 19/6/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).